All In Biotech

Drug Trial Radar · NCT06739213

A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma

SYHA1813 vs Investigators' Choice as Treatment for Recurrent or Progressive High-Grade Meningioma: A Randomized, Controlled, Multicenter, Phase II Study

Last checked: Nov 20, 2026Latest source record: Dec 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

56

Planned (sponsor's estimate)

Start

Jan 31, 2025

Primary completion

Jan 31, 2027

Study completion Jan 13, 2028

Sponsor

Sponsor type
Industry
First posted
Dec 18, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, controlled, open-label, multicenter, Phase II clinical study designed to evaluate the efficacy and safety of SYHA1813 compared to investigators' choice in participants with recurrent or progressive high-grade meningioma.

Conditions

  • Recurrent or Progressive High Grade Meningioma

Interventions

  • SYHA1813Drug

    The starting dose of SYHA1813 is 20mg QD

  • Investigator's Choice TreatmentDrug

    Investigator's Choice Treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the Progression-free survival (PFS) at 6-month(PFS-6)as evaluated by investigator (RANO-meningioma)Time frame: Up to approximately 3years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.